Quantitative 7T Phase Imaging in Premanifest Huntington Disease
暂无分享,去创建一个
S. Nelson | J. Kramer | J. Lupo | M. Geschwind | E. Johnson | C. P. Hess | D. Kelley | K. Possin | A. Apple | G. Satris | A. Jakary | K. Wong | G. Kang | S. Sha | C. Hess
[1] Julien Milles,et al. Texture analysis of ultrahigh field T2*‐weighted MR images of the brain: Application to Huntington's disease , 2014, Journal of magnetic resonance imaging : JMRI.
[2] S. Finkbeiner,et al. Executive functions in premanifest Huntington's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[3] J. R. Reichenbach,et al. Effect of Age on MRI Phase Behavior in the Subcortical Deep Gray Matter of Healthy Individuals , 2013, American Journal of Neuroradiology.
[4] J. Kramer,et al. New Sensitive Measures of Executive Functioning in Premotor Huntington's Disease (S20.002) , 2013 .
[5] Andrew G. Webb,et al. Elevated brain iron is independent from atrophy in Huntington's Disease , 2012, NeuroImage.
[6] Jane S. Paulsen,et al. Cognitive domains that predict time to diagnosis in prodromal Huntington disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[7] Torsten Rohlfing,et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.
[8] Jane S. Paulsen,et al. Indexing disease progression at study entry with individuals at‐risk for Huntington disease , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[9] R. Roos,et al. Seven-year clinical follow-up of premanifest carriers of Huntington's disease , 2011, PLoS currents.
[10] B. Leavitt,et al. Development of biomarkers for Huntington's disease , 2011, The Lancet Neurology.
[11] Stephen M. Smith,et al. A Bayesian model of shape and appearance for subcortical brain segmentation , 2011, NeuroImage.
[12] Jane S. Paulsen,et al. Neurocognitive signs in prodromal Huntington disease. , 2011, Neuropsychology.
[13] "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. , 2010, The Journal of neuropsychiatry and clinical neurosciences.
[14] Nick C Fox,et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data , 2009, The Lancet Neurology.
[15] D. Yablonskiy,et al. Biophysical mechanisms of phase contrast in gradient echo MRI , 2009, Proceedings of the National Academy of Sciences.
[16] E. Haacke,et al. Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.
[17] S. Nelson,et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron , 2008, Annals of neurology.
[18] G. Egan,et al. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.
[19] Bruce Fischl,et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. , 2008, Brain : a journal of neurology.
[20] Daniel B. Vigneron,et al. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases , 2008, NeuroImage.
[21] Jane S. Paulsen,et al. Detection of Huntington’s disease decades before diagnosis: the Predict-HD study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[22] Carlo Ciulla,et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain , 2007, Journal of magnetic resonance imaging : JMRI.
[23] Jim Mintz,et al. Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications , 2007, Neurochemical Research.
[24] Jane S. Paulsen,et al. Preparing for preventive clinical trials: the Predict-HD study. , 2006, Archives of neurology.
[25] Daniela Berg,et al. Role of Iron in Neurodegenerative Disorders , 2006, Topics in magnetic resonance imaging : TMRI.
[26] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[27] J. Ashburner,et al. Progression of structural neuropathology in preclinical Huntington’s disease: a tensor based morphometry study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[28] E. Haacke,et al. Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.
[29] Shihua Li,et al. Huntington and its Role in Neuronal Degeneration , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[30] Abraham Z. Snyder,et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume , 2004, NeuroImage.
[31] Petra Schmalbrock,et al. Enhanced gray and white matter contrast of phase susceptibility‐weighted images in ultra‐high‐field magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.
[32] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[33] N Makris,et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat , 2001, Neurology.
[34] G. Bartzokis,et al. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. , 2000, Cellular and molecular biology.
[35] G. Pearlson,et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[36] G. Bartzokis,et al. Increased basal ganglia iron levels in Huntington disease. , 1999, Archives of neurology.
[37] R M Henkelman,et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. , 1993, AJNR. American journal of neuroradiology.
[38] B Horwitz,et al. Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. , 1992, Archives of neurology.
[39] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.